Toth Financial Advisory’s AbbVie ABBV Stock Holding History

Toth Financial Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	59,705 +1,702	+3%	+$366K	1.47%	15
2026 Q1	$12.6M	Buy	58,003 +6,721	+13%	+$1.49M	1.38%	18
2025 Q4	$11.7M	Buy	51,282 +3,300	+7%	+$752K	1.27%	22
2025 Q3	$11.1M	Buy	47,982 +2,744	+6%	+$559K	1.2%	25
2025 Q2	$8.4M	Buy	45,238 +3,076	+7%	+$572K	0.98%	33
2025 Q1	$8.83M	Buy	42,162 +2,251	+6%	+$438K	1.06%	32
2024 Q4	$7.09M	Buy	39,911 +906	+2%	+$167K	0.83%	42
2024 Q3	$7.7M	Hold	39,005	–	–	0.91%	39
2024 Q2	$6.69M	Buy	39,005 +449	+1%	+$74.4K	0.85%	41
2024 Q1	$7.02M	Sell	38,556 -132	-0.3%	-$22.7K	0.88%	41
2023 Q4	$6M	Buy	38,688 +156	+0.4%	+$22.7K	0.81%	43
2023 Q3	$5.74M	Sell	38,532 -3,163	-8%	-$464K	0.87%	42
2023 Q2	$5.62M	Sell	41,695 -6,752	-14%	-$990K	0.81%	43
2023 Q1	$7.72M	Sell	48,447 -5,292	-10%	-$809K	1.2%	27
2022 Q4	$8.68M	Sell	53,739 -2,855	-5%	-$438K	1.41%	17
2022 Q3	$7.6M	Sell	56,594 -4,208	-7%	-$604K	1.37%	20
2022 Q2	$9.31M	Sell	60,802 -15,036	-20%	-$2.3M	1.62%	14
2022 Q1	$12.3M	Sell	75,838 -12,647	-14%	-$1.84M	1.84%	10
2021 Q4	$12M	Buy	88,485 +5,284	+6%	+$624K	1.63%	11
2021 Q3	$8.97M	Buy	83,201 +1,700	+2%	+$194K	1.36%	17
2021 Q2	$9.18M	Buy	81,501 +946	+1%	+$107K	1.4%	18
2021 Q1	$8.72M	Sell	80,555 -2,893	-3%	-$309K	1.39%	19
2020 Q4	$8.94M	Buy	83,448 +8,847	+12%	+$850K	1.53%	14
2020 Q3	$6.53M	Sell	74,601 -136	-0.2%	-$12.8K	1.25%	24
2020 Q2	$7.34M	Buy	74,737 +20,645	+38%	+$1.82M	1.59%	14
2020 Q1	$4.12M	Buy	54,092 +9,807	+22%	+$835K	1.19%	31
2019 Q4	$3.92M	Sell	44,285 -1,046	-2%	-$86.8K	0.8%	46
2019 Q3	$3.43M	Sell	45,331 -12,161	-21%	-$834K	0.75%	51
2019 Q2	$4.18M	Buy	57,492 +1,946	+4%	+$153K	0.94%	42
2019 Q1	$4.48M	Sell	55,546 -12,223	-18%	-$1,000K	1.05%	36
2018 Q4	$6.25M	Sell	67,769 -5,562	-8%	-$489K	1.71%	17
2018 Q3	$6.94M	Sell	73,331 -661	-0.9%	-$62.7K	1.54%	20
2018 Q2	$6.86M	Buy	73,992 +1,047	+1%	+$102K	1.61%	16
2018 Q1	$6.9M	Buy	72,945 +142	+0.2%	+$15.6K	1.68%	15
2017 Q4	$7.04M	Buy	72,803 +648	+0.9%	+$61.1K	1.67%	16
2017 Q3	$6.41M	Buy	72,155 +5,310	+8%	+$404K	1.62%	19
2017 Q2	$4.85M	Buy	66,845 +5,833	+10%	+$392K	1.27%	31
2017 Q1	$3.98M	Buy	61,012 +1,536	+3%	+$96.6K	1.06%	38
2016 Q4	$3.72M	Buy	59,476 +7,097	+14%	+$433K	1.07%	40
2016 Q3	$3.3M	Buy	52,379 +17,796	+51%	+$1.15M	0.97%	47
2016 Q2	$2.14M	Buy	34,583 +10,137	+41%	+$618K	0.65%	59
2016 Q1	$1.4M	Buy	24,446 +13,050	+115%	+$727K	0.46%	62
2015 Q4	$675K	Buy	11,396 +613	+6%	+$35.3K	0.22%	77
2015 Q3	$587K	Buy	10,783 +305	+3%	+$19.9K	0.22%	77
2015 Q2	$704K	Sell	10,478 -106	-1%	-$6.92K	0.24%	79
2015 Q1	$620K	Sell	10,584 -610	-5%	-$36.9K	0.21%	84
2014 Q4	$733K	Sell	11,194 -44	-0.4%	-$2.77K	0.25%	73
2014 Q3	$649K	Hold	11,238	–	–	0.24%	75
2014 Q2	$634K	Sell	11,238 -1,425	-11%	-$74.8K	0.24%	77
2014 Q1	$651K	Sell	12,663 -4,700	-27%	-$238K	0.26%	73
2013 Q4	$917K	Sell	17,363 -7,186	-29%	-$353K	0.39%	63
2013 Q3	$1.1M	Sell	24,549 -51,805	-68%	-$2.3M	0.51%	60
2013 Q2	$3.16M	Buy	+76,354	New	+$3.34M	1.55%	28

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Toth Financial Advisory's ABBV Position: Q2 2026 in Review

Toth Financial Advisory increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $366K and bringing the position to 59,705 shares worth $15M. The position accounts for 1.47% of the portfolio, ranked #15.

Toth Financial Advisory first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 933 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Toth Financial Advisory held 59,705 shares of AbbVie worth $15M as of Q2 2026.
Toth Financial Advisory bought 1,702 AbbVie shares in Q2 2026, an estimated $366K.
AbbVie made up 1.47% of Toth Financial Advisory's portfolio in Q2 2026, its #15 holding.
Toth Financial Advisory first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
933 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.